TABLE 4.
Possible Combination Number | Passive Ideation | Active Ideation | Method | Intent | Plan | Combinations Not Captured By FDA-CASA 2012 Titles | Combinations Not Captured By FDA-CASA 2012 Definitions | Combinations Not Captured By C–SSRS Titles | Combinations Not Captured By C–SSRS Definitions | Combinations Not Captured By C–SSRS Probe Questions | Do the FDA-CASA 2012 Titles & Definitions and the C–SSRS Titles, Definitions, & Probe Questions Capture This Combination? |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | Yes | |||||
2 | 0 | 1 | 0 | 0 | 0 | Yes | |||||
3 | 0 | 0 | 0 | 1 | 0 | ✓ | ✓ | ✓ | ✓ | ✓ | Overlooked |
4 | 0 | 1 | 0 | 1 | 0 | ✓ | No | ||||
5 | 0 | 0 | 1 | 0 | 0 | ✓ | ✓ | ✓ | ✓ | No | |
6 | 0 | 1 | 1 | 0 | 0 | Yes | |||||
7 | 0 | 0 | 1 | 1 | 0 | ✓ | ✓ | ✓ | ✓ | No | |
8 | 0 | 1 | 1 | 1 | 0 | ✓ | ✓ | ✓ | No | ||
9 | 0 | 0 | 0 | 0 | 1 | ✓ | ✓ | ✓ | ✓ | ✓ | Overlooked |
10 | 0 | 1 | 0 | 0 | 1 | ✓ | ✓ | ✓ | ✓ | No | |
11 | 0 | 0 | 0 | 1 | 1 | ✓ | ✓ | ✓ | ✓ | ✓ | Overlooked |
12 | 0 | 1 | 0 | 1 | 1 | ✓ | No | ||||
13 | 0 | 0 | 1 | 0 | 1 | ✓ | ✓ | ✓ | ✓ | No | |
14 | 0 | 1 | 1 | 0 | 1 | ✓ | ✓ | ✓ | ✓ | No | |
15 | 0 | 0 | 1 | 1 | 1 | ✓ | ✓ | ✓ | ✓ | No | |
16 | 0 | 1 | 1 | 1 | 1 | ✓ | ✓ | ✓ | No | ||
17 | 1 | 0 | 0 | 0 | 0 | Yes | |||||
18 | 1 | 1 | 0 | 0 | 0 | ✓ | ✓ | ✓ | ✓ | No | |
19 | 1 | 0 | 0 | 1 | 0 | ✓ | ✓ | ✓ | ✓ | No | |
20 | 1 | 1 | 0 | 1 | 0 | ✓ | ✓ | ✓ | ✓ | No | |
21 | 1 | 0 | 1 | 0 | 0 | ✓ | ✓ | ✓ | ✓ | No | |
22 | 1 | 1 | 1 | 0 | 0 | ✓ | ✓ | ✓ | ✓ | No | |
23 | 1 | 0 | 1 | 1 | 0 | ✓ | ✓ | ✓ | ✓ | No | |
24 | 1 | 1 | 1 | 1 | 0 | ✓ | ✓ | ✓ | ✓ | No | |
25 | 1 | 0 | 0 | 0 | 1 | ✓ | ✓ | ✓ | ✓ | No | |
26 | 1 | 1 | 0 | 0 | 1 | ✓ | ✓ | ✓ | ✓ | No | |
27 | 1 | 0 | 0 | 1 | 1 | ✓ | ✓ | ✓ | ✓ | No | |
28 | 1 | 1 | 0 | 1 | 1 | ✓ | ✓ | ✓ | ✓ | No | |
29 | 1 | 0 | 1 | 0 | 1 | ✓ | ✓ | ✓ | ✓ | No | |
30 | 1 | 1 | 1 | 0 | 1 | ✓ | ✓ | ✓ | ✓ | No | |
31 | 1 | 0 | 1 | 1 | 1 | ✓ | ✓ | ✓ | ✓ | No | |
32 | 1 | 1 | 1 | 1 | 1 | ✓ | ✓ | ✓ | ✓ | No | |
Total | 32 | 26 | 26 | 26 | 26 | 3 | Yes: 4 of 32; No: 25 of 32; Overlooked: 3 of 32 |
Note 1: This table summarizes most of the other tables into one. If the titles, definitions, and probe questions were consistent within the C–SSRS titles, definitions, and probe questions and consistent within the FDA-CASA 2012 titles and definitions, then the check marks in the columns titled “Combinations Not Captured…” should be consistent across every row. But they are not.
Note 2: There are ambiguities within the components of the FDA-CASA 2012 title, within the components of the FDA-CASA 2012 definition, within the components of the C-SSRS title, within the components of the C–SSRS definition, and within the components of the C–SSRS probe questions, and further ambiguities between the wording across the titles, definitions, and probe questions. This table ignores the ambiguities within the components of the titles, definitions, and probe questions and uses the best case scenario for interpretation.
C–SSRS: Columbia–Suicide Severity Rating Scale; FDA-CASA 2012: United States Food and Drug Administration-Classification Algorithm for Suicide Assessment